AT294795T
Substituted imidazole derivatives and their use as cytokine inhibitors
Abstract
For treating a novel 2,4,5 2,4,6-triaryl or.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
55 members in 25 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 81955192 | United States of America | A | |
| 86724992 | United States of America | A |
Members55
| Document | Office | Kind | |
|---|---|---|---|
| IL104369D0 | Israel | D0 | |
| CA2127876A1 | Canada | A1 | |
| CA2314425A1 | Canada | A1 | |
| CA2351694A1 | Canada | A1 | |
| CA2368862A1 | Canada | A1 | |
| WO9314081A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3592393A | Australia | A | |
| ZA93213B | South Africa | B | |
| CN1083473A | China | A | |
| NO942618D0 | Norway | D0 | |
| FR2700331A3 | France | A3 | |
| ES2053401A1 | Spain | A1 | |
| MX9300141A | Mexico | A | |
| NO942618L | Norway | L | |
| FI943319A | Finland | A | |
| HU9402092D0 | Hungary | D0 | |
| EP0623126A1 | European Patent Office (EPO) | A1 | |
| PT101273A | Portugal | A | |
| FR2700331B3 | France | B3 | |
| CZ168894A3 | Czechia | A3 | |
| WO9503297A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7629594A | Australia | A | |
| ES2053401B1 | Spain | B1 | |
| SK83594A3 | Slovakia | A3 | |
| ZA945363B | South Africa | B | |
| JPH07503017A | Japan | A | |
| BG98902A | Bulgaria | A | |
| HUT69714A | Hungary | A | |
| OA09963A | African Intellectual Property Organization (OAPI) | A | |
| RU94035756A | Russian Federation | A | |
| NZ249301A | New Zealand | A | |
| AU671271B2 | Australia | B2 | |
| BR9305809A | Brazil | A | |
| US5656644A | United States of America | A | |
| US5686455A | United States of America | A | |
| US5916891A | United States of America | A | |
| EP0943616A1 | European Patent Office (EPO) | A1 | |
| US6268370B1 | United States of America | B1 | |
| JP2002097189A | Japan | A | |
| JP3298641B2 | Japan | B2 | |
| US2003064997A1 | United States of America | A1 | |
| CA2127876C | Canada | C | |
| US6645989B2 | United States of America | B2 | |
| EP0623126B1 | European Patent Office (EPO) | B1 | |
| AT275556T | Austria | T | |
| ATE275556T1 | Austria | T1 | |
| DE69333616D1 | Germany | D1 | |
| ES2227517T3 | Spain | T3 | |
| EP0943616B1 | European Patent Office (EPO) | B1 | |
| AT294795TThis record | Austria | T | |
| ATE294795T1 | Austria | T1 | |
| DE69333805D1 | Germany | D1 | |
| DE69333616T2 | Germany | T2 | |
| ES2242351T3 | Spain | T3 | |
| DE69333805T2 | Germany | T2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 99201468
Titles2
- German
- SUBSTITUIERTE IMIDAZOLE DERIVATE UND IHRE VERWENDUNG ALS CYTOKIN INHIBITORE
- English
- Substituted imidazole derivatives and their use as cytokine inhibitors
Classification
- CPC, 18
- C07D401/04
- A61P7/02
- C07D403/04
- A61P9/00
- C07D413/14
- A61P11/00
- A61P11/06
- A61P13/12
- A61P17/06
- A61P19/00
- A61P19/02
- A61P19/08
- A61P19/10
- A61P29/00
- A61P31/10
- A61P37/00
- A61P37/06
- A61P43/00
- IPC, 35
- A61K31 4164
- A61K31 44
- A61K31 4427
- A61K31 4433
- A61K31 4439
- A61K31 4545
- A61K31 47
- A61K31 4709
- A61K31 4725
- A61K31 496
- A61K31 505
- A61K31 506
- A61K31 5377
- A61P7 02
- A61P9 00
- A61P11 00
- A61P11 06
- A61P13 12
- A61P17 06
- A61P19 00
- A61P19 02
- A61P19 08
- A61P19 10
- A61P29 00
- A61P31 10
- A61P37 00
- A61P37 06
- A61P43 00
- C07D233 56
- C07D401 04
- C07D401 14
- C07D403 04
- C07D409 14
- C07D413 14
- C07D417 14